ライフサイエンスコーパス: follow-up study

1 tudy) and 1993 to 1994 (Health Professionals Follow-Up Study).

2 A prospective follow-up study.

3 ' Health Study II), and Health Professionals Follow-Up Study.

4 adelphia Telemedicine Glaucoma Detection and Follow-up Study.

5 alth Study I and II and Health Professionals Follow-Up Study.

6 ne) using data from the Health Professionals Follow-Up Study.

7 the Multicenter Steroid Treatment Trial and Follow-up Study.

8 nd PS exposure were randomised in a one-year follow-up study.

9 sease and stroke in the Health Professionals Follow-Up Study.

10 rol group, as part of a prospective national follow-up study.

11 d Nutrition Examination Survey Epidemiologic Follow-up Study.

12 been validated in advanced generations in a follow-up study.

13 (90%) were enrolled in the Preterm Postnatal Follow-up Study.

14 anuary 31, 2010, in the Health Professionals Follow-up Study.

15 reflux symptoms (GERS) in a population-based follow-up study.

16 out in this Healthy Beginnings Trial phase 2 follow-up study.

17 , and 40,557 men in the Health Professionals Follow-up Study.

18 om a primary study have been replicated in a follow-up study.

19 reening visit (year 11) exited the long-term follow-up study.

20 control group were enrolled in the long-term follow-up study.

21 spill workers enrolled in the Gulf Long-Term Follow-up Study.

22 en aged >=50 y from the Health Professionals Follow-Up Study.

23 he 2002 study and 12.1% (50/413) in the 2013 follow-up study.

24 We therefore performed a long-term follow-up study.

25 iving cohort, 1092 (74%) participated in the follow-up study.

26 consecutively admitted for LT in a one-year follow-up study.

27 anish cohort, the SUN (University of Navarra Follow-Up) study.

28 rning and highlight the need for longer-term follow-up studies.

29 dentify factors associated with high quality follow-up studies.

30 directions in choosing families for detailed follow-up studies.

31 e number of candidate genes and pathways for follow-up studies.

32 ypertension justifies the need for long-term follow-up studies.

33 ritization of candidate genes for functional follow-up studies.

34 ganic free radical, and will be the focus of follow-up studies.

35 finding will be investigated in longitudinal follow-up studies.

36 aking them potential surrogate end points in follow-up studies.

37 se and to create a robust gene signature for follow-up studies.

38 les for pancreatic cancer that are worthy of follow-up studies.

39 tation, which will be used as a reference in follow-up studies.

40 provide testable hypotheses for mechanistic follow-up studies.

41 enes to assist in patient diagnosis and GWAS follow-up studies.

42 of APECED/APS1, that have spawned productive follow-up studies.

43 research program and prioritizing subsequent follow-up studies.

44 ercome these problems, the Preterm Postnatal Follow-up Study, 1 of the 3 main components of The Inter

45 In a follow-up study, 181 patients presenting with ST-segment

46 ) and 41,622 men in the Health Professionals Follow-Up Study (1986 to 2010) were included.

47 and 41,526 men from the Health Professionals Follow-Up Study (1986 to 2012) who were free of cancer,

48 013), and 43,259 men in Health Professionals Follow-up Study (1986 to 2012), free of chronic diseases

49 e cohort study uses the Health Professionals Follow-Up Study (1986 to 2012).

50 and 40,722 men from the Health Professionals Follow-up Study (1986-2008).

51 and 40,539 men from the Health Professionals Follow-Up Study (1986-2010), free of chronic diseases at

52 udy (1980-2010) and the Health Professionals Follow-up Study (1986-2010).

53 and 42,170 men from the Health Professionals Follow-Up Study (1986-2010)] who were free of CVD and ca

54 and 43,541 men from the Health Professionals Follow-up Study (1986-2012) who were free of chronic dis

55 ed up 34,224 men in the Health Professionals Follow-Up Study (1986-2012), 76,531 women in the Nurses'

56 h Study (1980-2010) and Health Professionals Follow-up Study (1986-2012), followed up 135965 health c

57 h Study (1984-2012) and Health Professionals Follow-up Study (1986-2012), following 1599 patients dia

58 and 39,434 men from the Health Professionals Follow-Up Study (1986-2012), who were free of cancer and

59 udy II (1991-2015), and Health Professionals Follow-up Study (1986-2012).

60 and 43,911 men from the Health Professionals Follow-up Study (1986-2016) who were free of CVD and can

61 udy II (1989-2016), and Health Professionals Follow-up Study (1986-2016).

62 2010), and 42,908 men (Health Professionals Follow-up Study, 1986 to 2010) who were free of diabetes

63 ealth Study: 1980-2014, Health Professionals Follow-Up Study: 1986-2014).

64 966 men from the HPFS (Health Professionals Follow-Up Study; 1990-2012).

65 ) and 32,959 men in the Health Professionals Follow-up Study (1992-2010) to investigate skin cancer r

66 I.MAX) Study (1994-2002) and the SU.VI.MAX 2 Follow-up Study (2007-2009).

67 cted over two pollen seasons (2013-2014) and follow-up study (204509) conducted 1 year later.

68 iomedical.Of 39 participants who were in the follow-up study, 29 subjects (CR: n = 18; control: n = 1

69 men; 1984-2012) and the Health Professionals Follow-up Study (41 094 men; 1986-2012) at each 2-year r

70 Most families in the follow-up study (421 [69.6%]) were low income; 680 (85.9

71 In two recent follow-up studies a role for TPC2 in pigmentation has be

72 We used data from the Gulf Long-term Follow-up Study, a cohort of workers and volunteers invo

73 369 mothers and their children completed the follow-up study, a phase 2 completion rate of 79.4% (80.

74 This long-term follow-up study aimed to assess the prognosis of systemi

75 This 2-year investigator-driven follow-up study aimed to determine whether improved grow

76 This follow-up study aimed to evaluate 24-month clinical outc

77 This follow-up study aimed to further characterize interactio

78 In a longitudinal follow-up study, all patients with genetically confirmed

79 In this long-term follow-up study among Nordic twins, there was significan

80 Our integrative approach streamlines GWAS follow-up studies and highlights a pleiotropic function

81 0 participants from the Health Professionals Follow-up Study and Nurses' Health Study using multivari

82 rns and CRC risk in the Health Professionals Follow-up Study and Nurses' Health Study.

83 imen forms the primary endpoint for the EBMT follow-up study and will be assessed annually for 4-7 ye

84 ealth Study) and 1994 (Health Professionals' Follow-up Study) and were followed through 2010.

85 eal-world databases, biomarker and long-term follow up studies, and research involving special groups

86 rses' Health Study, the Health Professionals Follow-up Study, and US national cancer statistics to ev

87 Longer-term follow-up studies are indicated.

88 Long-term follow-up studies are needed to confirm these results.

89 Further follow-up studies are needed to establish the long-term

90 Further follow-up studies are needed to investigate whether mate

91 Longitudinal follow-up studies are warranted to investigate BMI chang

92 Results of the ongoing MAVIDOS childhood follow-up study are awaited.

93 control group children were reenrolled in a follow-up study at 13 y of age (December 2012-June 2014)

94 There are limited long-term, single-cohort, follow-up studies available about patients after the Fon

95 We performed a follow-up study based on the Magnum 12+12 Cohort of pati

96 th an eligible genotype were enrolled in the follow-up study before the age of 4 months.

97 In this follow-up study, changes from baseline in rhinoconjuncti

98 nuary 31, 2010, for the Health Professionals Follow-up Study cohort, and data were accessed from Sept

99 This follow-up study comprised 137 305 men and 188 924 women

100 A follow-up study confirmed that immunization against only

101 In follow-up studies, control and RSD mice were subjected t

102 Follow-up studies demonstrated that hYVH1 co-localizes w

103 In conclusion, this follow-up study demonstrated circulating plasma exosomal

104 This follow-up study enrolled chronic hepatitis C patients to

105 rgical standard for HD, controlled long-term follow-up studies evaluating bowel function and QoL are

106 rgical standard for HD, controlled long-term follow-up studies evaluating bowel function and QoL are

107 in children is well established, but longer follow-up studies evaluating changes in the risk of card

108 these findings provide a strong platform for follow-up studies evaluating regulation of Spa47 oligome

109 ted thromboelastography maximum amplitude, a follow-up study evaluating platelet aggregation would be

110 A follow-up study examined the effects of CAPs exposure du

111 This follow-up study examined the long-term effect of the 12-

112 There are limited follow-up studies examining surgical and catheter-based

113 Our follow-up studies find that lower blood DICER1 expressio

114 This is the first detailed long-term follow-up study for patients with XLA, revealing that al

115 These reports remain controversial because follow-up studies from independent laboratories failed t

116 wed 43 479 men from the Health Professionals Follow-up Study from 1986 to 2012.

117 untries and travelers to these regions where follow-up studies have been performed.

118 Follow-up studies, however, have been limited, so that i

119 S) (n = 88,598) and the Health Professionals Follow-Up Study (HPFS) (n = 47,531) using repeated valid

120 ) and 25 907 men in the Health Professionals Follow-Up Study (HPFS) who were free from CVD and cancer

121 Health Study (NHS) and Health Professionals Follow-Up Study (HPFS) who were free of diabetes.

122 n's disease (PD) in the Health Professionals Follow-up Study (HPFS), a large prospective cohort of U.

123 and 40,744 men from the Health Professionals Follow-up Study (HPFS), both ongoing prospective cohort

124 dy (NHS), NHS2, and the Health Professionals Follow-up Study (HPFS), with 126,982 adult men and women

125 study nested within the Health Professionals Follow-Up Study (HPFS).

126 dy II (NHS II), and the Health Professionals Follow-up Study (HPFS).

127 udy (NHS, n = 1460) and Health Professionals Follow-up Study (HPFS, n = 1051).

128 lowed 41,808 men in the Health Professionals Follow-Up Study (HPFS; 1986-2012), 65,929 women in the N

129 and 41,412 men from the Health Professionals Follow-up Study (HPFS; 1986-2016) who were free of T2D,

130 6) and among men in the Health Professionals Follow-Up Study (HPFS; 1994-2008).

131 In follow-up studies in a murine model of intranasal Chlamy

132 g data from 377 LSL case-parent triads, with follow-up studies in an independent sample of 224 triads

133 t of lithium against AKI in rodents call for follow-up studies in humans and suggest that long-term t

134 Previous observational follow-up studies in humans suggest that increasing fitn

135 y is usually an essential first step for the follow-up studies in metagenomic research.

136 Follow-up studies in mutant mice revealed roles for RBP,

137 of infection should be further evaluated in follow-up studies in order to determine whether blocking

138 Finally, a long-term follow-up study in 1 iTTP patient showed that the open c

139 This was a longitudinal follow-up study in a self-selected subgroup of mother-in

140 This was a follow-up study in a subgroup of children from a randomi

141 18 years and in 1986) and at least once in a follow-up study in adulthood (2001, 2007, and 2011) were

142 We conducted a more extensive follow-up study in an independent sample of 1471 cases a

143 s in water arsenic and manganese: a two-year follow-up study in Bangladesh.

144 y (n = 887) were invited to participate in a follow-up study in June-August 2010 and were given the s

145 ounders did not change these results.In this follow-up study in preterm-born children, we showed that

146 3-y (2010-2013) prospective cohort household follow-up study in South Lima and Callao, Peru, measured

147 antly associated with pleural plaques in the follow-up study in terms of both the unadjusted hazard r

148 s' Health Study and the Health Professionals Follow-up Study in the United States.

149 ears and older from the Health Professionals Follow-up Study in the United States.

150 Our prospective follow-up study included only men who were nondiabetic a

151 Follow-up studies, including collaboration with the grou

152 The lack of long-term follow-up studies, including pathologic data, has led to

153 Selected effects were validated in a follow-up study, including several genes (ARL15, ZMIZ1,

154 m outcomes in disadvantaged families because follow-up studies indicate that benefits persist.

155 A prospective 30-year follow-up study interviewed individuals with documented

156 Long-term follow-up studies investigating whether elevated residua

157 In this follow-up study, investigators and participants remained

158 tory parameters evaluated in this short-term follow-up study, it can be concluded that OSFMUD can be

159 o June 1, 2012) and the Health Professionals Follow-up Study (June 1, 1986, to June 1, 2012) on a tot

160 ion with nonrecovery of activation change at follow-up studies may suggest a worse working memory out

161 The results of our research and the follow up studies might be used for the development of c

162 Follow-up studies might help explain the high frequency

163 dy (n = 31,615) and the Health Professionals Follow-up Study (n = 19,523).

164 ncer cohorts within the Health Professionals Follow-up Study (n = 249) and the Physicians' Health Stu

165 different cohorts: the Health Professionals Follow-up Study (n = 42,902 men), the Nurses' Health Stu

166 y II (n = 116,686), and Health Professionals Follow-up Study (n = 51,529)-reported physician-diagnose

167 In a follow-up study (N=329,000), a new EduYears GPS explains

168 imely re-interventions and avoid unnecessary follow up studies of lost transplants.

169 Moreover, we outline how follow-up studies of genetic findings using cellular sys

170 Follow-up studies of recipients of hepatitis B vaccine f

171 Follow-up studies of these couples showed a higher misca

172 In this long-term follow-up study of 2 randomized trials, prior randomized

173 In a long-term follow-up study of 2666 patients with chronic HBV infect

174 We conducted a follow-up study of 966 children aged 4-6 y in 2016, born

175 Setting, and Participants: This is a 3-year follow-up study of a cluster randomized clinical trial o

176 We undertook a nationwide follow-up study of a cohort of 1241 simple congenital he

177 This is the second phase of a 10-year follow-up study of a cohort of 176 patients with LAR of

178 This is a prospective 10-year follow-up study of a large multicenter cohort from North

179 This was a prospective follow-up study of a noninferiority, open-label, randomi

180 An investigator-driven, real-life follow-up study of adult-onset steroid-naive, newly diag

181 of CR in nonobese humans.We conducted a 2-y follow-up study of adults who underwent 2 y of CR or ad

182 f 3 surveys in Finland (Health 2000, 2004/05 Follow-up Study of Adults' Oral Health, and Health 2011)

183 in such trials using data from a prospective follow-up study of an incident cohort of PD patients.

184 a from a longitudinal, ultrasonography-based follow-up study of Beninese women.

185 Nationwide register-based follow-up study of Covid-19 patients in Denmark until Ma

186 Importance: This follow-up study of extremely preterm (EPT) children (<27

187 This study is the largest and longest follow-up study of functional limb weakness.

188 In 3-year follow-up study of individuals initially diagnosed with

189 were then enrolled in a separate open-label follow-up study of long-term safety.

190 In conclusion, in this long-term follow-up study of older adults, domestic work and cycli

191 onsider interesting to perform a prospective follow-up study of patients who require a transplant to

192 ment and cerebrospinal fluid biomarkers in a follow-up study of patients with VZV encephalitis.

193 sign, Setting, and Participants: Prospective follow-up study of persons with type 1 or type 2 diabete

194 We report a 20-year follow-up study of statin therapy in children.

195 men) from the Rotterdam Study, a prospective follow-up study of subjects aged 55 years or older in th

196 TENOR II was a follow-up study of TENOR I patients using a single cross

197 In a longitudinal register-based follow-up study of the Copenhagen Child Cohort 2000, a t

198 We implemented a follow-up study of the initial, community-based cluster-

199 A longitudinal follow-up study of the randomized clinical Healthy Begin

200 This is a long-term follow-up study of the same cohort of patients previousl

201 We did a follow-up study of the Supplementation with Multiple Mic

202 The study is a follow-up study of the TIME-trial (traditional invasive

203 This work includes a follow-up study of therapies, focusing on the long-term

204 Follow-up studies on cases with available outcome result

205 Our work paves the way for follow-up studies on these fascinating pathways and allo

206 October 2017 ( ISRCTN17160440 ) and the EBMT follow-up study on 19th January 2018 ( ISRCTN31981313 ).

207 Six-year follow-up study on the effects of PHO withdrawal on IgE

208 electing the ideal cohorts or cell types for follow-up studies or in developing predictive models.

209 al (18)F-FET uptake, which was reversible in follow-up studies or negative shortly before and without

210 urses' Health Study and Health Professionals Follow-Up Study participants with archived RBC specimens

211 All studies collected biological samples and followed-up study participants prospectively for subsequ

212 Should our results be confirmed by long-term follow-up studies, POEM may become one of the first-line

213 the lack of critical data from longitudinal follow-up studies precludes valid conclusions on possibl

214 lar across sex, geographic region, length of follow-up, study quality, and method of expressing prote

215 In functional follow-up studies, rare height-increasing alleles of STC

216 Long-term follow-up studies regarding disease-related complication

217 re participating in the Health Professionals Follow-Up Study reported information on insomnia symptom

218 ts with type 2 diabetes from 36 trials and 9 follow-up studies reporting cardiovascular outcomes and

219 To dimension follow-up studies, researchers need to accurately estima

220 Follow-up studies reveal a temporal shift in PPK onset i

221 Long-term follow up study revealed three phenotypes of neurodegene

222 Follow-up studies revealed that the putative ubiquitin l

223 In a prospective follow-up study (Sample 2, n=45), the effects of an inte

224 te the success of recent RPE65 gene therapy, follow-up studies show that patients continue to experie

225 Follow-up studies show that the patients recovered well

226 Follow-up studies showed that YAP1, a transcriptional ef

227 529 men enrolled in the Health Professionals Follow-up Study since 1986 to determine the association

228 69 +/- 8 years) in the Health Professionals Follow-up Study since 2004, without a history of stroke.

229 ort Study (SJLIFE) and the St Jude Long-term Follow-up Study (SJLTFU).

230 od samples, Army STARRS and its longitudinal follow-up study (STARRS-LS) are designed to identify pot

231 prevent cellular remodeling, and (3) trigger follow-up studies that address both, the molecular mecha

232 Follow-up studies that will further investigate hepadnav

233 laucoma (OAG) in migraineurs using a 10-year follow-up study that employed a nationwide population-ba

234 have now addressed this knowledge gap with a follow-up study that identified MNT as a promising molec

235 udy, a prospective, population-based 32-year follow-up study that included participants aged 3-18 yea

236 At the 6-week follow-up study, the female MTBI group showed persistent

237 In this follow-up study, the first of its kind in the UK, volunt

238 In the follow-up study, the primary outcome measure was the pro

239 For patients with at least one follow-up study, time-to-event analysis was performed to

240 and they and their children participated in follow-up studies to assess subsequent health outcomes.

241 We suggest possible follow-up studies to confirm these hypotheses.

242 ity and illustrates the need for longer-term follow-up studies to determine whether abnormal activati

243 Follow-up studies to evaluate the involvement of CAR in

244 enerating tool, the results of which justify follow-up studies to explore the influence of the grape

245 udy identified several potential targets for follow-up studies to further evaluate and determine if t

246 We performed a small molecule screen and follow-up studies to seek a novel therapy.

247 We conduct follow-up studies to verify the dependency of JEV on the

248 cinoma (ESCC) in Han Chinese, we conducted a follow-up study to examine the single nucleotide polymor

249 s' Health Study and the Health Professionals Follow-Up Study, to examine the role of yogurt consumpti

250 The patients could enter a long-term follow-up study until 1 year after allogeneic hematopoie

251 Follow-up studies using previously reported GWAS meta-an

252 Follow-up studies using TMA with wild type versus eosino

253 A follow-up study using consecutive backcrosses from Dahl

254 Follow-up studies utilizing biochemical, metabolic, and

255 Follow-up studies validated the role of eight additional

256 Follow-up study visits for recipients were scheduled 4-6

257 Baseline and 5-year follow-up study visits included computed tomography scan

258 ndpoint at month 12 and then protocol-driven follow-up study visits were conducted at months 18 and 3

259 r Uveitis Steroid Treatment (MUST) Trial and Follow-up Study was a randomized comparative effectivene

260 An observational follow-up study was carried out for 1 year following vac

261 A follow-up study was conducted at 14 academic hospitals i

262 The rate of adherence to avoidance in the follow-up study was high (90.4% in the peanut-avoidance

263 ts on health are sustainable.The aim of this follow-up study was to compare body size, body compositi

264 of follow-up, including the current extended-follow-up study, was 9.8 years.

265 In follow-up studies, we depleted "accessible cholesterol"

266 Upon completion of follow-up studies, we developed the working model that s

267 In recent follow-up studies, we discovered that sensitivity to tio

268 In this pre-specified follow-up study, we aimed to assess additional treatment

269 urses' Health Study and Health Professionals Follow-up Study, we associated intake of caffeinated and

270 In this long-term follow-up study, we collected our trial outcomes from th

271 s' Health Study and the Health Professionals Follow-up Study, we did not find a significant associati

272 In this 1-year follow-up study, we evaluated the effects of community-b

273 Using a 26-year follow-up study, we examined whether childhood exposure

274 of participants in the Health Professionals Follow-up Study, we found that long-term adherence to a

275 course-taking in high school; in the current follow-up study, we found that the intervention improved

276 In this follow-up study, we investigated whether AnxA1 could be

277 In this follow-up study, we investigated whether interventions h

278 In this follow-up study, we investigated whether the rate of pea

279 Here, in a follow-up study, we obtained a chemically-synthesized ve

280 After 4 weeks of follow-up (study week 16), unmasking occurred and patien

281 group, average ss values at both initial and follow-up studies were lower compared with those in the

282 Follow-up studies were performed at 7, 21, and 61 days.

283 Primary outcomes of this follow-up study were (1) a cognitive factor score based

284 udy and 38,961 men from Health Professionals Follow-Up Study were followed up from 1984 to 2012 and f

285 group were invited to enrol in the long-term follow-up study, which extended follow-up for 7 addition

286 hort were eligible for the Preterm Postnatal Follow-up Study, which included standardised anthropomet

287 ormed within 1 month after the injury, and a follow-up study, which was performed 6 weeks after the f

288 and 38 961 men from the Health Professionals Follow-Up Study who were at least 50 years old, from 198

289 ata on 2,299 men in the Health Professionals Follow-up Study who were diagnosed with nonmetastatic pr

290 clinical trial followed by an observational follow-up study) who completed the 25-item National Eye

291 was 34,940 men from the Health Professionals Follow-Up Study, who were healthy and free of periodonta

292 Longitudinal follow-up studies will be necessary to ascertain the lon

293 Follow-up studies will clarify the processes and evoluti

294 Long-term follow-up studies will confirm the safety of LV-based ge

295 e development of this technology in detailed follow-up studies will yield highly innovative diagnosti

296 Follow-up studies with a second set of conjugates target

297 A prospective follow-up study with FMF-amyloidosis and glomerulonephro

298 In a follow-up study with the Zn-selected populations, we obs

299 prostate cancer in the Health Professionals Follow-Up Study, with a focus on lethal and high-grade d

300 y and 40,278 men in the Health Professionals Follow-Up Study without a history of cardiovascular dise